Compare Moderna, Inc. (MRNA) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs US Bancorp — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: US Bancorp is far larger — about 4.2× Moderna, Inc.'s market cap, and US Bancorp pays a 3.29% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | USB | |
|---|---|---|
Market Cap | $23.60B | $98.36B |
Sector | Health | Financials |
52-Week High | $81.80 | $64.01 |
52-Week Low | $22.36 | $43.94 |
Enterprise Value | $19.70B | — |
Dividend Yield | — | 3.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
